- Home
- GAN vs ASMB Comparison
GAN vs ASMB Comparison
Compare GAN & ASMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GAN
- ASMB
- Stock Information
- Founded
- GAN 1999
- ASMB 2005
- Country
- GAN United States
- ASMB United States
- Employees
- GAN N/A
- ASMB N/A
- Industry
- GAN Computer Software: Programming Data Processing
- ASMB Biotechnology: Pharmaceutical Preparations
- Sector
- GAN Technology
- ASMB Health Care
- Exchange
- GAN Nasdaq
- ASMB Nasdaq
- Market Cap
- GAN 83.4M
- ASMB 97.8M
- IPO Year
- GAN 2020
- ASMB 2010
- Fundamental
- Price
- GAN $1.84
- ASMB $14.28
- Analyst Decision
- GAN
- ASMB Buy
- Analyst Count
- GAN 0
- ASMB 2
- Target Price
- GAN N/A
- ASMB $35.00
- AVG Volume (30 Days)
- GAN 242.8K
- ASMB 35.1K
- Earning Date
- GAN 11-08-2024
- ASMB 11-07-2024
- Dividend Yield
- GAN N/A
- ASMB N/A
- EPS Growth
- GAN N/A
- ASMB N/A
- EPS
- GAN N/A
- ASMB N/A
- Revenue
- GAN $134,024,000.00
- ASMB $28,326,000.00
- Revenue This Year
- GAN $5.97
- ASMB $248.93
- Revenue Next Year
- GAN $11.32
- ASMB $35.28
- P/E Ratio
- GAN N/A
- ASMB N/A
- Revenue Growth
- GAN N/A
- ASMB N/A
- 52 Week Low
- GAN $1.17
- ASMB $8.76
- 52 Week High
- GAN $1.87
- ASMB $19.93
- Technical
- Relative Strength Index (RSI)
- GAN 55.01
- ASMB 36.57
- Support Level
- GAN $1.81
- ASMB $14.75
- Resistance Level
- GAN $1.86
- ASMB $15.94
- Average True Range (ATR)
- GAN 0.02
- ASMB 0.84
- MACD
- GAN -0.00
- ASMB -0.13
- Stochastic Oscillator
- GAN 50.00
- ASMB 4.00
About GAN GAN Limited
GAN Ltd provides Software-as-a-Service solutions for online casino gaming and sports betting applications. The company has two operating segments B2B and B2C. The B2B segment develops, markets, and sells instances of GameSTACK, GAN Sports, and iSight Back Office technology that incorporates comprehensive player registration, account funding, and back-office accounting and management tools that enable the casino operators to efficiently, confidently, and effectively extend their presence online in places that have permitted online real money gaming, and The B2C segment, which includes the operations of Coolbet, develops and operates a B2C online sports betting and casino platform that is accessible through its website in markets across Northern Europe, Latin America, and Canada.
About ASMB Assembly Biosciences Inc.
Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two innovative platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.